A summary of four recent studies evaluating locoregional therapies for hepatocellular carcinoma and percutaneous ablation for ...
Practical guidance from a high-volume center on procedural planning, team coordination, carotid access, and technical ...
Jupiter Endovascular, Inc. announced that the full results of the SPIRARE II pivotal trial, evaluating the company’s Vert ...
Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...
Srinivas Attanti, MD, FACC Cardiologist and Interventional Cardiologist Citrus Cardiology Consultants, PLLC Florida ...
Real-world evidence comparing TCAR with TFCAS and CEA across surgical risk and symptom status and the role of the ENROUTE™ ...
Haemonetics Corporation announced FDA approval of the PerQseal Elite vascular closure system for large-bore arterial procedures ...
Stryker Peripheral Vascular announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) ...
The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...
Results from the prospective, single-arm, multicenter POWER PAD II study demonstrated that the Pulse intravascular lithotripsy ...
Endovascular Engineering, Inc. (E2), a developer of technology for venous thromboembolism, announced FDA 510(k) clearance for b ...
A secondary analysis of the randomized SirPAD trial demonstrated lower rates of target-lesion revascularization (TLR) and major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results